01/23/2018 12:00 AM EST
Source: Access to Medicine Foundation. Published: 1/23/2018. This 185-page report is the first independent analysis of pharmaceutical company action against antimicrobial resistance, covering antimicrobial R&D, responsible manufacturing, and appropriate access and stewardship. It has evaluated 30 pharmaceutical companies, including those with the largest R&D divisions, the largest market presence, and specific expertise in developing critically needed medicines and vaccines. (PDF)
.png)
No hay comentarios:
Publicar un comentario